SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

DUATTI, Adriano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.216
AS - Asia 6.374
EU - Europa 4.610
SA - Sud America 1.284
AF - Africa 107
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 8
Totale 25.619
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.943
SG - Singapore 2.595
CN - Cina 1.944
BR - Brasile 1.109
DE - Germania 877
UA - Ucraina 834
IT - Italia 742
HK - Hong Kong 615
GB - Regno Unito 556
TR - Turchia 439
PL - Polonia 372
FI - Finlandia 346
SE - Svezia 320
VN - Vietnam 308
RU - Federazione Russa 196
MX - Messico 133
CA - Canada 113
IN - India 105
FR - Francia 90
ID - Indonesia 72
AR - Argentina 56
ZA - Sudafrica 54
BD - Bangladesh 49
NL - Olanda 49
BE - Belgio 45
JP - Giappone 41
ES - Italia 39
IQ - Iraq 32
AT - Austria 29
EC - Ecuador 27
IR - Iran 24
CZ - Repubblica Ceca 23
UZ - Uzbekistan 23
VE - Venezuela 23
CH - Svizzera 21
AU - Australia 18
CO - Colombia 18
LT - Lituania 17
MA - Marocco 17
PK - Pakistan 16
PY - Paraguay 16
CL - Cile 14
BG - Bulgaria 13
SA - Arabia Saudita 12
TW - Taiwan 12
KE - Kenya 10
AE - Emirati Arabi Uniti 9
KR - Corea 9
RO - Romania 9
EG - Egitto 8
UY - Uruguay 8
AZ - Azerbaigian 7
BO - Bolivia 6
EU - Europa 6
HU - Ungheria 6
IL - Israele 6
LB - Libano 6
LV - Lettonia 6
MY - Malesia 6
PA - Panama 6
DZ - Algeria 5
HN - Honduras 5
JO - Giordania 5
OM - Oman 5
IE - Irlanda 4
JM - Giamaica 4
KG - Kirghizistan 4
NP - Nepal 4
SY - Repubblica araba siriana 4
CR - Costa Rica 3
GA - Gabon 3
GR - Grecia 3
GY - Guiana 3
MN - Mongolia 3
PE - Perù 3
PH - Filippine 3
PS - Palestinian Territory 3
BN - Brunei Darussalam 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GE - Georgia 2
KZ - Kazakistan 2
MK - Macedonia 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
GT - Guatemala 1
KH - Cambogia 1
KW - Kuwait 1
LI - Liechtenstein 1
Totale 25.605
Salva come PNG Salva come JPEG
Città #
Singapore 1.480
Woodbridge 1.166
Fairfield 1.163
Ashburn 1.110
Houston 909
Jacksonville 844
Chandler 760
Ann Arbor 721
Santa Clara 642
Hong Kong 612
Beijing 543
Wilmington 502
Seattle 463
Warsaw 363
Cambridge 348
Nanjing 264
Izmir 256
Munich 237
Los Angeles 204
Princeton 195
Ferrara 194
Addison 186
New York 146
Dallas 129
Milan 128
São Paulo 122
The Dalles 119
San Diego 113
Helsinki 112
Boardman 101
Falkenstein 96
Ho Chi Minh City 95
Shenyang 94
Mexico City 89
Nanchang 80
Shanghai 75
Hefei 71
Tianjin 67
Council Bluffs 66
Turku 63
Dearborn 60
San Mateo 60
Falls Church 59
Dong Ket 57
Hanoi 57
Hebei 57
London 54
Buffalo 53
Changsha 53
Chicago 44
Redwood City 43
Brooklyn 42
Jakarta 41
Bremen 40
Stockholm 40
Tokyo 40
Brussels 38
Jiaxing 38
Rio de Janeiro 37
Moscow 35
Denver 33
Toronto 33
Nuremberg 32
Chennai 31
Montreal 31
Belo Horizonte 30
Boston 30
Amsterdam 29
San Francisco 29
Auburn Hills 28
Phoenix 28
Jinan 27
Johannesburg 27
Kunming 27
Ningbo 27
Brasília 26
Frankfurt am Main 26
Guangzhou 26
Orem 25
Poplar 25
Atlanta 24
Bologna 24
Norwalk 24
Zhengzhou 24
Tashkent 22
Curitiba 20
Washington 19
Des Moines 18
Mumbai 18
Padova 18
Querétaro 18
Vienna 18
Ankara 17
Augusta 17
Legnaro 17
Rome 17
Taizhou 16
Guarulhos 15
Mountain View 15
Philadelphia 15
Totale 16.822
Salva come PNG Salva come JPEG
Nome #
In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals 465
14 MeV neutrons for 99Mo/99mTc production: Experiments, simulations and perspectives 350
Preclinical SPECT-CT imaging studies with cyclotron produced Tc-99m 288
LARAMED: A Laboratory for Radioisotopes of Medical Interest 239
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 238
E-learning as a tool to harmonize education and good quality assurance system in radiopharmacy 235
A solvent-extraction module for cyclotron production of high-purity technetium-99m 223
A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma 214
YAP-(S)PET small animal scanner: Quantitative results 213
Technetium(V)-nitrido complexes of dithiocarbazic acid derivatives. Reactivity of (Tc=N)2+ core towards Schiff bases derived from S-methyl dithiocarbazate. Crystal structures of (S-methyl-3-(2-hydroxyphenyl-methylene) dithiocarbazato) nitrido (triphenylphosphine) Technetium(V) and bis(S-methyl-3- isopropylidene dithiocarbazato) nitrido Technetium(V). 204
An alternative approach to the preparation of (188)Re radiopharmaceuticals from generator-produced [(188)ReO(4)]:(-) efficient synthesis of (188)Re(V)-meso-2,3-dimercaptosuccinic acid 203
Remotely controlled solvent extraction of high purity Tc-99m produced by conventional medical cyclotrons 202
A new solvent-extraction module for a local routine production of technetium-99m by medical cyclotrons 202
Formation of the Tc≡N multiple bond from the reaction of ammonium pertechnetate with S-methyl dithiocarbazate and its application to the preparation of technetium-99m radiopharmaceuticals 188
Synthesis and Structure of an Amino Sugar-Schiff Base Complex of Technetium(V) Containing Salicylaldehyde in an Unusual Coordination Mode 185
Communicating across the boundaries 185
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 184
Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma 183
Synthesis of hybrid distamycin-cysteine labeled with 99mTc: a model for a novel class of cancer imaging agents 182
A novel approach to the high-specific-activity labeling of small peptides with the technetium-99m fragment [Tc-99m(N) (PXP)](2+) (PXP = diphosphine ligand) 182
Development of an Automatic Separation/Extraction Module for the Accelerator 99mTc Production from 100Mo-Enriched Molybdenum Metal Targets 179
Geometrically controlled selective formation of nitrido technetium(V) asymmetrical heterocomplexes with bidentate ligands 178
Tc(IV)Cl4(PPh3)2 and Tc(III)Cl3(CH3CN)(PPh3)2 as precursors of trans dioxo technetium(V) complexes with chelating amines and tetraazamacrocycles 176
STRUCTURE OF TRANS-TRICHLOROBIS[DIETHYL(PHENYL)PHOSPHINE]HYDROXORHENIUM(IV) 175
Whole-Body Biodistribution and Radiation Dosimetry of the New Cardiac Tracer 99mTc-N-DBODC 174
THE STRUCTURE OF TRANS-DIBROMOOXO(N-PHENYLSALICYLIDENEAMINATO)(TRIPHENYLPHOSPHINE)RHENIUM (V), FORM-II (TRICLINIC), [REBR2(C13H10NO)O(P(C6H5)3)] 172
A small animal hybrid PET-SPECT scanner: First in-vivo results. 172
Labeling of Fatty Acid Ligands with the Strong Electrophilic Metal Fragment [99mTc(N)(PNP)]2+ (PNP=Diphosphane Ligand) 170
A Study on the Gamma-Ray Background of the Images Obtained Using Accelerator- Produced 99mTc 170
Design and synthesis of a redox-active Tc-99m radiopharmaceutical with ferrocenedithiocarboxylate [FcCS = Fe(C5H4CS2)(C5H5)-] 169
First evaluation in humans of the new myocardial perfusion imaging agent 99mTcN-dbodc: safety, biodistribution and dosimetry assessment 168
Photochemical synthesis and reaction of d6 metallocenes—tetracyanoethylene charge-transfer complexes 167
Association of Co(sep)3+ ions with S2O32- ions: Spectrophotometric, circular dichroism and solubility measurements 166
Synthesis, properties and X-ray crystal structure of Schiff base organo-imido complexes of rhenium(V) 165
The emerging role of copper-64 radiopharmaceuticals as cancer theranostics 165
Isolation and Crystal Structure of a Technetium(V) Nitrido Complex Containing a Coordinated Transient State of N-(2-Aminoethyl)carbamic Acid 164
Erratum: A kit formulation for the preparation of 188Re- lipiodol: Preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma (Nuclear Medicine Communication (2004) 25 (691-699)) 164
Radiofarmaci 164
The chemistry of heteroallyl derivatives of technetium. Reactivity of [TcNCl2(PPh3)2] and [Tc(CO) 3Cl(PPh3)] with thiazetidine ligands, crystal structures of [Tc(CO)2(PPh3)2{PhN=C(OEt)S}] and [TcN(Cl)(PPh3)-{PhN=C(OEt)S}] 164
Synthesis of a novel class of nitrido Tc-99m radiopharmaceuticals with phosphino-thiol ligands showing transient heart uptake 163
First Accelerator-Based 99mTc GBq Production Levels and in-vivo Imaging Tests for APOTEMA Experiment 163
Synthesis and characterization of technetium-(IV) and -(III) complexes with bidentate Schiff bases. X-ray molecular structure of chloro(dimethylphenylphosphine)bis(N-phenylsalicylideneiminato)technetium(III) 162
Synthesis, reactivity and X-ray crystal structures of mixed thiazolato- or carboxylato-carbonyl(phosphine)-rhenium(I) complexes 161
Mixed tridentate π-donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals 159
Chemistry of the strong electrophilic metal fragment [99Tc(N)(PXP)]2+ (PXP = diphosphine ligand). A novel tool for the selective labeling of small molecules 158
Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies 158
Synthesis and X-ray crystal structure of the mixed organoimido, organoamine rhe-nium(V) complex [ReCl3(NC6H4Me-p)(NH2C6H4Me-p)PPh3] 157
Extraction techniques of 99mTc from 100Mo Metal Target 157
The chemistry of heteroallene and heteroallyl derivatives of rhenium. Part 1. Reactiv-ity of mixed carbonyl(formamido)(phosphine)rhenium(I) complexes with RNCS (R = Ph or p-MeC6H4) and PhNCO. Crystal structure of the thiazetidine rhenium(I) com-plex [Re(CO)2(PPh3)2PhN=C(OEt)-S] 156
RHENIUM(V) COMPLEXES WITH VINYL AMIDES 156
Synthesis and characterization of paramagnetic schiff base complexes of rhenium(IV) 154
Development of new 99mTc-labeled bisphosphonates for bone scintigraphy 154
Crystal structure of trans-dicarbonylbis (dimethylphenylphoshine)(N-phenylsalicyl ideneaminato) rhenium(I) and mer-trichloro (dimethylphenylphosphine)(N-phenylsalicyl ideneaminato) rhenium(IV). Comparison of Re(I), Re(III), Re(IV) and Re(V) complexes with salicylideneaminato ligand and reaction mechanism. 153
The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)](2+) metal fragments (M = Tc, Re; PXP = diphosphine ligand) 152
Radioisotopic purity and imaging properties of cyclotron-produced 99mTc using direct100Mo(p,2n) reaction 151
Influence of the Generator in-Growth Time on the Final Radiochemical Purity and Stability of Radiopharmaceuticals 150
Molecular imaging with endogenous and exogenous ligands: the instance of antibodies, peptides, iodide and cupric ions 150
Chemistry and Bifunctional Chelating Agents for Binding Lu-177 150
Technetium(V)-nitrido complexes of dithiocarbazic acid derivatives. Reactivity of [Tc≡N]2+ core towards Schiff bases derived from S-methyl dithiocarbazate. Crystal structures of [S-methyl 3-(2-hydroxyphenylmethylene)dithiocarbazato]nitrido(triphenylphos-phine)technetium(V) and bis(S-methyl 3-isopropylidenedithiocarbazato)nitridotechnetium(V) 149
Complexes of Tc(V) and Tc(III) with tridentate Schiff bases derived from S-Methyl dithiocarbazate. Crystal structures of chloro-[S-methyl-3-(2-hydroxy-1-naphtyl methylene) dithiocarbazato(2-)]oxotechnetium(V) and dichloro[S-methyl-3-(2-hydroxybenzilidene) dithiocarbazato(1)]bis (triphenylphosphine) technetium(III). 149
Clearance of technetium 99m N-NOET in normal, ischemic-reperfused, and membrane-disrupted myocardium 147
PREPARATION AND CHARACTERIZATION OF MIXED AMIDO, CARBOXYLATO OR THIAZOLATO CARBONYL(PHOSPHINE)TECHNETIUM(I) COMPLEXES 146
Safety profile, biodistribution and dosimetry of the new myocardial perfusion imaging agent [99mTc]N.DBODC: first evaluation in Human. 146
Progress using Tc-99m radiopharmaceuticals for measuring high capacity sites and low density sites 146
Technetium-99m nitrido radiopharmaceuticals with unprecedented biological properties 145
A remotely controlled module for an in-hospital routine production of Tc-99m by medical cyclotrons 145
A new efficient method for the preparation of 99mTc-radiopharmaceuticals containing the TcN multiple bond 144
Reactivity of rhenium(I) pseudo-allyl complexes with heterocumulenes. Part 2. Inser-tion reactions. Crystal structures of the thiazolyl-thioureido and -dithiocarbamato complexes [Re(CO)2(PPh3)2SC(NPh)NMe(C3H2NS)] ·CH2Cl2 and [Re(CO)2(PPh3)2S2CNMe(C3H2NS)]·CH2Cl2 (C3H2NS = thiazol-2-yl) 142
POLAROGRAPHIC AND SPECTROPHOTOMETRIC INVESTIGATION OF THE REDUCTION AND DEPROTONATION OF (1,3,6,8,10,13,16,19-OCTA-AZABICYCLO-[6,6,6]-ICOSANE)COBALT(III) ION, CO(SEP)3+, IN THE PRESENCE OF DIFFERENT ANIONS 142
Technetium and rhenium heterocomplexes containing the diphenylphosphinoferrocenyl fragment 141
Synthesis and characterization of nitrido Tc(V) and Re(V) complexes with ferrocenedithiocarboxylate {FcCS(2)=[Fe(C5H4CS2)(C5H5)](-)} 141
Technetium(V) nitrido complexes with tetra-azamacrocycles: monocationic and neu-tral octahedral complexes containing the [Tc≡N]2+ core. Crystal structure of [TcN(L1)(H2O]·2H2O (H2L1 = 1,4,8,11-tetra-azacyclotetradecane-5,7-dione) 141
Esophageal substitute using the Sparks prosthesis. Experimental study 141
Bis(dithiocarbamato) nitrido technetium-99m radiopharmaceuticals: A class of neutral myocardial imaging agents 140
Synthesis and x-ray crystal structure of the mixed organoimido, organoamine rhenium(V) complex ReCl3(NC6H4Me-p)(NH2C6H4Me-p)PPh3] 140
Mixed schiff base, carbonyl(phosphine)rhenium(I) complexes 139
Reactions of the Technetium(I) Carbonyl Complexes [Tc(PMe2Ph)3(CO)2Cl] and [Tc(PPh3)2(CO)3Cl] toward Pseudoallyl Ligands Such as Triazenido, Formamidinato, and Acetamidinato. Crystal Structures of [Tc(PMe2Ph)2(CO)2(p-CH3C6H4N-N-NC6H4CH3-p)] and [Tc(PMe2Ph)2(CO)2(C6H5N-C(CH3)-NC6H5)] 139
A Comparison of Separation and Purification Strategies for 51/52Mn cyclotron production 139
REDOX PROPERTIES OF A SERIES OF PSEUDOALLYL RHENIUM(I) COMPLEXES 138
Reactivity of Schiff base rhenium(V) complexes with dimethylphenylphosphine 138
Synthesis of Technetium(V)-Nitrido Complexes with Chelating Amines: A Novel Class of Monocationic, Octahedral Complexes Containing the [Tc≡N]2+ Core. Crystal Structures of [TcN(en)2Cl]+ (en = Ethylenediamine) and [TcN(tad)Cl]+ (tad = 1,5,8,12-T etraazadodecane) 138
Asymmetrical nitrido Tc-99m heterocomplexes: A class of cardiac agents with unprecedented imaging properties. 137
Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules 137
Technetium complexes and radiopharmaceuticals with scorpionate ligands 137
The chemistry of heteroallene and heteroallyl derivatives of rhenium. Part 2. Reactiv-ity of [ReO(OR)Cl2(PPh3)2] (R = Me or Et) with RNCS ( R = Ph or p-MeC6H4). Crystal structure of the thiazetidine rhenium(V) complex [ReOCl2(PPh3) p-MeC6H4N=C(OEt)-S] 136
Crystal structures of trans-dicarbonylbis(dimethylphenylphosphine)(N-phenylsalicyl-ideneaminato)rhenium(I) and mer-trichloro(dimethylphenylphosphine)(N-phenyl-salicylideneaminato)rhenium(IV). Comparison of ReI, ReIII, ReIV, and ReV complexes with salicylideneaminato ligand and reaction mechanisms 136
Labeling and biodistribution studies of Tc-99m radiopharmaceuticals with (o-hydroxyphenyl)diphenylphosphine 135
Rhenium(V) and Technetium(V) Nitrido Complexes with Mixed 2 Tridentate pigreco-Donor and Monodentate pigreco-Acceptor Ligands 135
Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties 135
PEGylated N-methyl-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of nitrido Tc-99m and Re-188 radiopharmaceuticals 135
Is PET always an advantage versus planar and SPECT imaging? 134
Synthesis, solution-state and solid-state structural characterization of monocationic nitrido heterocomplexes [M(N)(DTC(PNP)](+) (M=Tc-99, Re; DTC = dithiocarbamate; PNP = heterodiphosphane) 133
In vivo imaging of oligonucleotides with nuclear tomography 132
Nonisotopic substitution: Is fluorine a replacement for hydrogen? 132
A class of asymmetrical nitrido Tc-99m heterocomplexes as heart imaging agents with improved biological properties 130
Incorporation of a glucose moiety in a technetium-99m nitrido compound 129
BIODISTRIBUTION IN MAN OF BIS [(N-ETHYL, N-ETHOXY) DITHIOCARBAMATE] NITRIDO TECHNETIUM-(V), A PROMISING NEW TRACER FOR MYOCARDIAL PERFUSION IMAGING 128
Radiochemical Puritiy Of 99mTc-HMPAO: some Considerations on Routine Radiopharmaceuticals Preparation 127
Advances in radiopharmaceuticals for cardiac imaging: 99mTcN-NOET 127
Reactivity of 2-(2-hydroxyphenyl)benzothiazoline with the oxotetrahalometalate(V) complexes [MOX4]- (M = technetium, rhenium; X = Cl, Br). Synthesis and characterization of new oxo-M(V) complexes containing 2-(2-hydroxyphenyl)benzothiazole. Crystal structure of tetraphenylarsonium oxotrichloro[2-(2-hydroxyphenyl)benzothiazolato]technetate(V) 127
Totale 16.549
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.226
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 10.545
Totale 133.771
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.584 0 0 0 0 0 233 75 326 86 338 363 163
2021/20222.175 79 200 169 95 141 75 90 122 81 158 287 678
2022/20231.758 211 123 44 220 250 273 102 148 189 22 125 51
2023/2024968 91 113 81 39 63 104 71 64 19 28 29 266
2024/20254.825 137 94 332 148 510 312 246 358 724 609 909 446
2025/20266.047 1.129 432 916 1.600 1.771 199 0 0 0 0 0 0
Totale 25.920